Vir Biotechnology (VIR) Operating Income (2018 - 2025)
Historic Operating Income for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$173.4 million.
- Vir Biotechnology's Operating Income rose 2501.51% to -$173.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$548.6 million, marking a year-over-year increase of 992.95%. This contributed to the annual value of -$587.2 million for FY2024, which is 1419.54% up from last year.
- Vir Biotechnology's Operating Income amounted to -$173.4 million in Q3 2025, which was up 2501.51% from -$118.4 million recorded in Q2 2025.
- Vir Biotechnology's 5-year Operating Income high stood at $1.0 billion for Q1 2022, and its period low was -$231.3 million during Q3 2024.
- In the last 5 years, Vir Biotechnology's Operating Income had a median value of -$139.5 million in 2025 and averaged -$23.6 million.
- The largest annual percentage gain for Vir Biotechnology's Operating Income in the last 5 years was 73910.28% (2022), contrasted with its biggest fall of 46911.35% (2022).
- Vir Biotechnology's Operating Income (Quarter) stood at $571.8 million in 2021, then crashed by 126.32% to -$150.5 million in 2022, then increased by 7.63% to -$139.0 million in 2023, then grew by 15.73% to -$117.2 million in 2024, then tumbled by 48.05% to -$173.4 million in 2025.
- Its Operating Income was -$173.4 million in Q3 2025, compared to -$118.4 million in Q2 2025 and -$139.5 million in Q1 2025.